心血管康复医学杂志
心血管康複醫學雜誌
심혈관강복의학잡지
JOURNAL OF CARDIOVASCULAR REHABILITATION MEDICINE
2015年
3期
300-303
,共4页
陈盈文%吴焱贤%李彩华%杨友%陈玉映%张奕文%罗德谋
陳盈文%吳焱賢%李綵華%楊友%陳玉映%張奕文%囉德謀
진영문%오염현%리채화%양우%진옥영%장혁문%라덕모
高血压%主动脉疾病%氨氯地平%艾司洛尔
高血壓%主動脈疾病%氨氯地平%艾司洛爾
고혈압%주동맥질병%안록지평%애사락이
Hypertension%Aortic diseases%Amlodipine%Esmolol
目的:探讨盐酸艾司洛尔联合苯磺酸氨氯地平治疗高血压合并主动脉夹层对患者血压及心率的影响。方法:高血压合并主动脉夹层患者110例,被随机分为氨氯地平组和联合用药组(氨氯地平+艾司洛尔),各55例。结果:与治疗前相比,治疗0.5、1.5、7h后两组患者收缩压和舒张压均明显下降(P<0.01),治疗7h后,联合用药组患者收缩压显著低于氨氯地平组[(101.5±7.8) mmHg比(123.4±10.2) mmHg , P<0.01]。治疗0.5、1.5、7h后,联合用药组患者心率、脉率乘积(RPP)均显著低于氨氯地平组(P均<0.01)。治疗后,与氨氯地平组比较,联合用药组患者的血压达标率(56.36%比87.27%)、心率达标率(38.18%比92.73%)、心率血压同时达标率(25.45%比81.82%)显著提高( P均<0.01)。结论:盐酸艾司洛尔联合苯磺酸氨氯地平片治疗高血压合并主动脉夹层患者,能够快速、安全、有效地控制血压和心率。
目的:探討鹽痠艾司洛爾聯閤苯磺痠氨氯地平治療高血壓閤併主動脈夾層對患者血壓及心率的影響。方法:高血壓閤併主動脈夾層患者110例,被隨機分為氨氯地平組和聯閤用藥組(氨氯地平+艾司洛爾),各55例。結果:與治療前相比,治療0.5、1.5、7h後兩組患者收縮壓和舒張壓均明顯下降(P<0.01),治療7h後,聯閤用藥組患者收縮壓顯著低于氨氯地平組[(101.5±7.8) mmHg比(123.4±10.2) mmHg , P<0.01]。治療0.5、1.5、7h後,聯閤用藥組患者心率、脈率乘積(RPP)均顯著低于氨氯地平組(P均<0.01)。治療後,與氨氯地平組比較,聯閤用藥組患者的血壓達標率(56.36%比87.27%)、心率達標率(38.18%比92.73%)、心率血壓同時達標率(25.45%比81.82%)顯著提高( P均<0.01)。結論:鹽痠艾司洛爾聯閤苯磺痠氨氯地平片治療高血壓閤併主動脈夾層患者,能夠快速、安全、有效地控製血壓和心率。
목적:탐토염산애사락이연합분광산안록지평치료고혈압합병주동맥협층대환자혈압급심솔적영향。방법:고혈압합병주동맥협층환자110례,피수궤분위안록지평조화연합용약조(안록지평+애사락이),각55례。결과:여치료전상비,치료0.5、1.5、7h후량조환자수축압화서장압균명현하강(P<0.01),치료7h후,연합용약조환자수축압현저저우안록지평조[(101.5±7.8) mmHg비(123.4±10.2) mmHg , P<0.01]。치료0.5、1.5、7h후,연합용약조환자심솔、맥솔승적(RPP)균현저저우안록지평조(P균<0.01)。치료후,여안록지평조비교,연합용약조환자적혈압체표솔(56.36%비87.27%)、심솔체표솔(38.18%비92.73%)、심솔혈압동시체표솔(25.45%비81.82%)현저제고( P균<0.01)。결론:염산애사락이연합분광산안록지평편치료고혈압합병주동맥협층환자,능구쾌속、안전、유효지공제혈압화심솔。
Objective:To explore therapeutic effect of esmolol hydrochloride combined amlodipine on patients with hyper-tension complicated aortic dissection (AD) and its influence on patient's blood pressure (BP) and heart rate (HR) .Meth-ods:A total of 110 patients with hypertension complicated AD were randomly and equally divided into amlodipine group and combined treatment group (received amlodipine and esmolol) .Results:Compared with before treatment , after treat-ment 0. 5 ,1. 5 and 7h ,there were significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in both groups ,P<0.01 ,on 7h after treatment ,SBP level of combined treatment group significantly reduced than that of amlodipine group [(101.5 ± 7.8) mmHg vs .(123.4 ± 10.2) mmHg ,P<0.01];on 0.5 ,1.5 and 7h after treatment ,HR and rate pressure product (RPP) of combined treatment group significantly reduced than those of amlodipine group , P<0. 01 all. Compared with amlodipine group after treatment , there were significant rise in standard-reaching rates of BP (56.36% vs .87.27% ) ,HR (38.18% vs .92.73% ) and BP+HR (25.45% vs .81.82% ) in combined treatment group , P<0.01 all. Conclusion:Esmolol combined amlodipine can control blood pressure and heart rate rapidly ,safely and effec-tively in patients with hypertension complicated aortic dissection .